Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Effects of biochemically confirmed smoking cessation on white blood cell count.

Abel GA, Hays JT, Decker PA, Croghan GA, Kuter DJ, Rigotti NA.

Mayo Clin Proc. 2005 Aug;80(8):1022-8.

PMID:
16092581
2.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
3.

Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.

Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DP, Buist AS, Hurt RD.

J Gen Intern Med. 2004 Aug;19(8):828-34.

4.

A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.

Fossati R, Apolone G, Negri E, Compagnoni A, La Vecchia C, Mangano S, Clivio L, Garattini S; General Practice Tobacco Cessation Investigators Group.

Arch Intern Med. 2007 Sep 10;167(16):1791-7.

PMID:
17846399
5.

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD.

Ann Intern Med. 2001 Sep 18;135(6):423-33.

PMID:
11560455
6.

A comparison of sustained-release bupropion and placebo for smoking cessation.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

N Engl J Med. 1997 Oct 23;337(17):1195-202.

7.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
8.

The effect of bupropion sustained-release on cigarette craving after smoking cessation.

Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, Rigotti N, Sachs DP.

Clin Ther. 2002 Apr;24(4):540-51.

PMID:
12017399
9.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
10.

Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants.

Chengappa KN, Kambhampati RK, Perkins K, Nigam R, Anderson T, Brar JS, Vemulapalli HK, Atzert R, Key P, Kang JS, Levine J.

J Clin Psychiatry. 2001 Jul;62(7):503-8.

PMID:
11488359
12.

A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR.

Biol Psychiatry. 2002 Jul 1;52(1):53-61.

PMID:
12079730
13.

A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.

Hays JT, Hurt RD, Decker PA, Croghan IT, Offord KP, Patten CA.

Nicotine Tob Res. 2009 Jul;11(7):859-67. doi: 10.1093/ntr/ntp077. Epub 2009 May 29.

14.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643
15.

Outcomes from an outpatient smoking-cessation clinic.

Roth MT, Andrus MR, Westman EC.

Pharmacotherapy. 2005 Feb;25(2):279-88.

PMID:
15767242
16.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
17.

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB.

N Engl J Med. 1999 Mar 4;340(9):685-91.

18.

Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.

Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP.

Nicotine Tob Res. 2009 Jun;11(6):663-9. doi: 10.1093/ntr/ntp047. Epub 2009 Apr 24.

PMID:
19395688
19.

Effects of gender on relapse prevention in smokers treated with bupropion SR.

Gonzales D, Bjornson W, Durcan MJ, White JD, Johnston JA, Buist AS, Sachs DP, Rigotti NA, Niaura R, Hays JT, Hurt RD.

Am J Prev Med. 2002 May;22(4):234-9.

PMID:
11988379
20.

Development of depression during placebo-controlled trials of bupropion for smoking cessation: case reports.

Patten CA, Rummans TA, Croghan IT, Hurt RD, Hays JT.

J Clin Psychiatry. 1999 Jul;60(7):436-41.

PMID:
10453796

Supplemental Content

Support Center